Table 4.
Serum antibody and cytokine levels in patients with echinococcosis treated surgically with or without anaphylactic shock (N = 90)
| Shock (N = 18) | Control (N = 72) | P value† | |
|---|---|---|---|
| Anti-EgCF antibody, n (%) | |||
| + | 4 (22.22) | 11 (13.75) | 0.003* |
| ++ | 11 (61.11) | 16 (20.00) | |
| +++ | 3 (16.67) | 53 (66.25) | |
| Anti-EgP antibody, n (%) | |||
| + | 4 (22.22) | 8 (10.00) | 0.907 |
| ++ | 12 (66.67) | 72 (90.00) | |
| +++ | 2 (11.11) | 0 (0.00) | |
| Anti-EgB antibody, n (%) | |||
| − | 1 (5.56) | 1 (1.25) | 0.003* |
| + | 2 (11.11) | 9 (11.25) | |
| ++ | 12 (66.67) | 15 (18.75) | |
| +++ | 3 (16.67) | 55 (68.75) | |
| Anti-Em2 antibody, n (%) | |||
| – | 3 (16.67) | 5 (6.25) | 0.147 |
| + | 15 (83.33) | 75 (93.75) | |
anti-EgCF = crude hydatid cyst fluid antigen; anti-EgB = hydatid cyst fluid native antigen B; anti-Em2 = Echinococcus multilocularis metacestode antigen.
*
Indicates a significant difference between those with and without anaphylactic shock.
†
The data were analyzed using the Fisher's exact test or the χ2 test.